Editorial commentary: how can understanding the phenotype of Pseudomonas aeruginosa lead to more successful eradication strategies in cystic fibrosis?

Affiliations

Editorial

Valerie Waters. Clin Infect Dis. 2014.

. 2014 Sep 1;59(5):632-4.

doi: 10.1093/cid/ciu388. Epub 2014 May 26.

¹ Division of Infectious Diseases, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Ontario, Canada.

No abstract available

Keywords: Pseudomonas; cystic fibrosis; eradication.

Comment on

Risk of pneumococcal disease in children with chronic medical conditions in the era of pneumococcal conjugate vaccine.
Pelton SI, Weycker D, Farkouh RA, Strutton DR, Shea KM, Edelsberg J. Pelton SI, et al. Clin Infect Dis. 2014 Sep 1;59(5):615-23. doi: 10.1093/cid/ciu348. Epub 2014 May 13. Clin Infect Dis. 2014. PMID: 24825867
Pseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis.
Mayer-Hamblett N, Ramsey BW, Kulasekara HD, Wolter DJ, Houston LS, Pope CE, Kulasekara BR, Armbruster CR, Burns JL, Retsch-Bogart G, Rosenfeld M, Gibson RL, Miller SI, Khan U, Hoffman LR. Mayer-Hamblett N, et al. Clin Infect Dis. 2014 Sep 1;59(5):624-31. doi: 10.1093/cid/ciu385. Epub 2014 May 26. Clin Infect Dis. 2014. PMID: 24863401 Free PMC article. Clinical Trial.